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Abstract A facile fabrication method to produce bio-
compatible semiconductor Quantum Dots encapsulated in
high quality and thick thermal oxide is presented. The
process employs sonication of porous Si/SiO2 structures to
produce ﬂakes with dimension in the 50–200 nm range.
These ﬂakes show a coral-like SiO2 skeleton with Si
nanocrystals embedded in and are suitable for functional-
ization with other diagnostic or therapeutic agents. Silicon
is a biocompatible material, efﬁciently cleared from the
human body. The Photoluminescence emission falls in the
transparency window for living tissues and is found to be
bright and stable for hours in the aggressive biological
environment.
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Introduction
The production of functional nanomaterials for therapeutic
and diagnostic purposes is one of the major challenges of
nowadays nanotechnology [1, 2]. The intrinsic properties
of such nanostructures, say, the efﬁcient photolumines-
cence [3, 4], the strong superparamagnetism [5], or the
characteristic Raman signatures [6], combined with the
large speciﬁc capacity for drug loading [7] allow to fore-
cast wide application in the biological and medical ﬁelds.
However, the size and charge of most nanoparticles pre-
clude their efﬁcient clearance from the body as intact
nanoparticles. Without such clearance or their biodegra-
dation into biologically benign components, toxicity is
potentially ampliﬁed [8]. On the other hand, rapid renal
excretion [8], observed with particle diameters\5.5 nm, is
often undesirable because the relatively short residence
time do not allow the nanoparticles to carry out their
action.
This discussion points out on the importance of the
nanoparticles engineering in terms of size and composition
but also addresses on the rates of self-destruction and the
formation of non-toxic, renally cleared products.
Among the various kinds of functional nanomaterials,
semiconductor Quantum Dots (QD) received particular
attention [3, 4, 9]. These are nanoparticles in which charge
carriers are three-dimensionally conﬁned. The quantum
conﬁnement provides size-tunable absorption bands and
emission color to QDs. The photoluminescence (PL) of
QDs is exceptionally bright and stable, with very narrow
emission but broad absorption spectra, making them
potential candidates for biomedical imaging and thera-
peutic interventions, but concerns persist about their safety
[10]. Most toxicology data are derived from in vitro studies
and may not reﬂect in vivo responses, so the fear of toxicity
greatly prevented their employment in studies in vivo.
Encapsulation in SiO2 shells [4, 11, 12] is a promising
approach for biophotonic applications where hydrophilic-
ity, biocompatibility, and low rates of self-destruction are
needed.
In the present scenario, an interesting possibility is
offered by Si QDs. Silicon is well known as a biocom-
patible material [13], widely used in nanomedicine [14]o r
in bone growth [15]. In Si nanocrystals with diameter down
to 1–3 nm, the exciton quantum conﬁnement is the
mechanism at the base of the bright, visible photolumi-
nescence [16]. This effect is easily observed in Porous
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high-resistivity p-type substrates [17] or by stain etching
[18]. The energy position and FWHM of the PL spectrum
is related to the average size and dispersion of the nano-
particles composing the PS nanosponge [19]. Moreover,
the electrical behavior of PS can be tuned from insulating
to semiconducting (p-, or n-type), independently on the
doping type and level of the starting substrate [20].
A recent paper [21] reports on the use of Si nanoparti-
cles, derived from luminescent PS, as biodegradable opti-
cal markers and drug delivery agents. The investigated
Si nanoparticles have diameters of 100–200 nm and are
agglomerates of single luminescent nanocrystals. PL is
centered in the near-IR and quite stable, thanks to oxidation
during activation of PL in aqueous solution. Such a struc-
ture is particularly interesting for two reasons. First, it
avoids renal ﬁltration, prolonging the residence time in the
living body; second, its porous structure, reminiscent of the
pristine PS, allows for incorporation of drugs and for their
slow release.
In the present paper, an alternative method to achieve
efﬁcient SiO2 encapsulation, with more durable PL and
lower degradation in biological solution, is presented.
Experimental
Materials and Methods
The starting PS samples are obtained by anodizing p
?
substrates (1 mX cm,\100[oriented). Such material is
well known to be composed by nanocrystals with average
dimension[10 nm, somewhat smaller in high-porosity
samples. As a consequence for the weak excitonic con-
ﬁnement, the resulting PS is poorly photoluminescent. It
has been demonstrated, however, that oxidation in dry O2
at 1000C greatly enhances the PL, with intensity compa-
rable to conventional PS from p-type substrates [22]. This
is related to the controlled growth of the SiO2 shell which
reduces the Si core to a few nm and to the superior pas-
sivating properties of the thermal oxide. In fact, thermal
oxide is well known [23] to be nearly stoichiometric, and
the spin density at the Si/SiO2 interface has been evaluated
to be small [22].
Oxide Growth
The PS samples have been oxidized in an horizontal quartz
tube at O2 atmospheric pressure. A ﬁrst, pre-oxidation step
at 300C has been carried out in order to reduce surface
Si atoms mobility, preventing in this way the structure
collapse at the oxidation temperature (1000C).
Figure 1 reports the thickness of the SiO2 shell, as
extracted by analyzing gravimetric data taken from a PS
sample with 60% porosity [20]. A AND microbalance with
10
-5 g sensitivity has been used for the purpose. The sat-
uration at about 5 nm is related to the full conversion of Si
crystallites (10 nm average diameter) into SiO2. In Fig. 2,
the gravimetric data are displayed showing the O/Si ratio as
a function of porosity for two oxidation times. A saturated
value of O/Si = 2 is reached upon the total conversion of
the Si skeleton into SiO2. The comparison of the two
graphs allows to predict both the Si core diameter and the
thickness of the SiO2 shell by a proper choice of the sample
porosity and oxidation time. For the present work, porosity
varied between 40 and 60%, whereas oxidation duration
was in the 10–40 min range.
PS Structuring
Because of the low samples porosity and the high degree of
oxidation, the volume expansion due to Si conversion into
SiO2 cannot be neglected. In fact, the pore coalescence has
been reported [22]: this effect, especially for the lower
porosities prevents O2 molecules diffusion and ﬁxation into
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Fig. 1 Oxide thickness on a 60% porosity PS layer, as a function of
oxidation time, calculated according to ref. [22]
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Fig. 2 O/Si ratio, as a function of the sample porosity, for two
different oxidation times
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123the pores. Of course, this is detrimental to the QD pas-
sivation. To circumvent this problem, we produced PS
multilayers by alternating 40-nm LP (low porosity) and
40-nm HP (high porosity) layers, by means of periodic
variations of the anodizing current in the aqueous HF/
ethanol electrolyte. As an example, 100 periods comprising
steps of 10/220 mA cm
-2 were applied by means of a
Keithley 2400 programmable current source. Samples have
been cleaved before oxidation. The HP layers act as
channels for lateral O2 diffusion into the porous structure,
allowing for the uniform oxidation of the LP layers.
Nanoparticle Production
The samples were then sonicated for 6–8 h in toluene,
obtaining a suspension composed by two classes of nano-
particles. The ﬁrst class of\10 nm SiO2 particles derives
from the HP layers, whereas the second class is composed
by Si/SiO2 nanoﬂakes originating from LP regions. The
dimension of such nanoﬂakes ranges from 50 to 300 nm
and can be separated by the SiO2 nanoparticles by means of
a 20-nm membrane ﬁlter. A second ﬁltration step, using a
200-nm membrane, allows for further size selection of the
Si/SiO2 nanoﬂakes.
Characterization Results
Electron Microscopy
The typical structure of a large ([300 nm) Si/SiO2 nano-
ﬂake is shown in Fig. 3. The TEM micrograph shows
darker, nearly spherical dots, i.e., the Si nanocrystals,
embedded in the SiO2 matrix. Both the thickness of this
encapsulating ﬁlm and the Si QDs diameter are consistent
with the previous evaluations. The bright spots and the halo
in the diffraction pattern reported in the inset indicates the
presence of both amorphous (SiO2) and crystalline (Si)
phases. The magniﬁed view conﬁrms the crystallinity of
the Si nanodots.
Interesting features of the nanoﬂakes obtained in this
way are the coral-like structure and the large speciﬁc sur-
face. Both can be fruitfully employed to add further
functionalities, e.g., embedded magnetic nanodots, drugs,
and other ﬂuorophores.
Photoluminescence
By means of a Sciencetech monochromator with f/4.5
aperture, equipped with an EG&G cooled multichannel
detector, the PL emitted by Si/SiO2 nanoﬂakes under Hg
illumination has been analyzed.
Light emission is centered in the near-IR, as shown in
Fig. 4, and exceptionally stable in ambient conditions,
being unaltered after 2 weeks of air exposure.
The PL stability is obviously crucial when QDs are
incubated into biological systems. This test has been car-
ried out by immersing the nanoﬂakes into a PBS (phos-
phate-buffered saline) solution at T = 37C and pH = 7.5.
The PL color remains dark red and the intensity reduces to
60% in about 4 h of incubation, a very different behavior
respect to [21], where the optical emission is reported to
start decreasing just after incubation. After 4 h of
Fig. 3 TEM Micrograph of a Si/SiO2 nanoﬂake, with maximum
axis[300 nm, showing the coral-like structure and the encapsu-
lated Si nanodots. Inserts shows the electron diffraction pattern
(left bottom), and a magniﬁed image of the Si nanodots structure (A)
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Fig. 4 PL spectra from Si/SiO2 nanoﬂakes. Bold line shows the
emission spectrum before incubation in PBS. Thin line: after 240-min
incubation time. Dashed spectrum is collected after 270-min incuba-
tion time
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123incubation, the QDs emission blue-shifts and decreases
more abruptly, consistently to what reported in [21]. This
different behavior is easily explained in terms of thickness
and quality of the SiO2 encapsulation. In the present case,
the very thick silica layer is hardly consumed by the PBS
solution, whereas the following PL quenching and blue-
shifting are signatures for the consumption of the Si
ﬂuorophores.
Biocompatibility
There are several reports about the biocompatibility of Si
nanostructures, most of them related to the PS itself which is
a particularly interesting material in the present case, since
our nanoﬂakes directly derive from it. First biocompatibility
tests were carried out a decade ago [24], and more recently,
implants of PS into living tissues have been carried out,
without the observation of any inﬂammatory reactions [25].
It is well known, on the other hand, that Si is a common
trace element in humans, and a biodegradation product of
porous silicon, orthosilicic acid (Si(OH)4), is the form
predominantly absorbed by humans and is naturally found
in numerous tissues [26].
Silicic acid release from the dots was measured by
placing the nanoﬂakes into a speciﬁed volume of PBS and
ﬁtting a screw-cap to ensure the volume was sealed.
Samples of the incubating solution were taken at 1-day
intervals, measuring 400 ll. Data have been compared with
those taken from a c-Si sample and an untreated PS
membrane.
Analysis was by a molybdenum (molybdate) blue assay,
in which ammonium molybdate in solution reacts with
silicic acid in the sample to form silicomolybdic acid
(yellow) which is subsequently reduced to form a molyb-
date blue complex with a peak absorbance at 810 nm.
Silicic acid concentration standards were prepared with
sodium metasilicate pentahydrate analysis.
The data reported in Fig. 5 show the relatively slow
releaseofSi(OH)4fromoxidizednanoﬂakes,comparedwith
unoxidized PS. Saturation occurring after 3 days for nano-
ﬂakes is related to the full consumption of sample’s mass,
which is considerably lower than in the other two cases.
It seems that, at the present level if investigation, a
possible toxic effect of Si nanodots could be related with
O2 radicals, as proposed by Fujioka et al. [27]. It has to be
stressed, however, that those authors observed such cyto-
toxic effect only at high concentration.
Conclusions
The method here described allows for producing very
stable and efﬁcient Si-based ﬂuorophores, with improved
resistance to biological agents, and emitting in the near-IR
window for light transmission of living tissues. Si/SiO2
nanoﬂakes selected in the 50–200 nm range do not undergo
the renal ﬁltration, whereas silica encapsulation allows
long residence times in the living body, a necessary con-
dition for the nanoparticles to carry out their action. The
coral-like structure of the nanoﬂakes allows for the incor-
poration of other diagnostic and therapeutic agents.
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